Clinical Trial Update: Memory Improvement With Docosahexaenoic Acid Study (MIDAS) [NA]

View source ↗

Summary

MIDAS is a clinical trial testing whether docosahexaenoic acid improves memory in people with age-related cognitive decline or age-related memory disorders; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Cognitive Decline
• Age-related Memory Disorders

Drugs mentioned

• Docosahexaenoic acid (docosahexaenoic acid)

Snippet

Sponsor: dsm-firmenich Switzerland AG | Conditions: Age-Related Cognitive Decline, Age-Related Memory Disorders | NA | Status: COMPLETED